首页 | 本学科首页   官方微博 | 高级检索  
     

帕尼培南/倍他米隆治疗重症感染30例临床疗效及安全性分析
引用本文:连江山,刘薇,黄建荣. 帕尼培南/倍他米隆治疗重症感染30例临床疗效及安全性分析[J]. 中国微生态学杂志, 2011, 23(3): 239-240
作者姓名:连江山  刘薇  黄建荣
作者单位:1. 浙江大学医学院附属第一医院,感染科,浙江,杭州,310003
2. 浙江大学医学院附属第一医院,传染病诊治国家重点实验室,浙江,杭州,310003
基金项目:艾滋病和病毒性肝炎等重大传染病防治科技重大专项(2008ZX10002-005)
摘    要:目的探讨帕尼培南/倍他米隆治疗重症感染临床疗效及安全性。方法 30例临床诊断为重症感染的患者静脉应用帕尼培南/倍他米隆1.0 g/8 h,观察患者临床症状、体征转归及实验室指标变化。结果应用帕尼培南/倍他米隆治疗重症感染30例,痊愈15例,显效10例,死亡1例,总有效率达83.3%。细菌培养结果阳性16例,培养阳性率为53.3%,细菌清除率为88.8%,不良反应率为6.7%。结论帕尼培南/倍他米隆治疗重症感染有较好的临床疗效,不良反应率低。

关 键 词:帕尼培南  倍他米隆  临床疗效  重症感染

Analysis of efficacy and safety of panipenem/betamipron in treatment of 30 patients with severe bacterial infection
LIAN Jiang-shan,LIU Wei,HUANG Jian-rong. Analysis of efficacy and safety of panipenem/betamipron in treatment of 30 patients with severe bacterial infection[J]. Chinese Journal of Microecology, 2011, 23(3): 239-240
Authors:LIAN Jiang-shan  LIU Wei  HUANG Jian-rong
Affiliation:LIAN Jiang-shan,LIU Wei,HUANG Jian-rong (The First Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou 310003,China)
Abstract:Objective To investigate the efficacy and safety of panipenem/betamipron initially used for severe bacterial infection patients. Method Patients clinically diagnosed with severe bacterial infection were treated with panipenem/betamipron,1.0 g intravenously once every eight hours. Result The effective rate of panipenem/betamipron used for severe bacterial infection patients was 83.3%;the bacterial eradication rate was 88.8%,and the adverse reaction rate was 6.7%. Conclusion Panipenem/betamipron is effective ...
Keywords:Panipenem  Betamipron  Curative effect  Severe infection  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号